Recent studies identified an oxidant-sensitive subset of estrogen/ER-responsive breast cancer genes linked to cell growth and invasion pathways that was associated with loss of progesterone receptor and earlier disease-specific mortality [53]. Here, PGR is linked to breast carcinoma.